|
May 6
|
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
|
|
May 6
|
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
|
|
May 6
|
BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline
|
|
May 6
|
What's Going With BioNTech Stock On Monday?
|
|
May 6
|
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
|
|
May 6
|
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
|
|
May 6
|
BioNTech says 90% of 2024 revenues will accrue at end of year
|
|
May 6
|
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
|
|
May 3
|
Stocks to watch next week: BP, Saudi Aramco, Uber, and interest rates
|
|
May 3
|
Why Earnings Season Could Be Great for BioNTech (BNTX)
|
|
Apr 30
|
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
|
|
Apr 25
|
Wall Street plunges after US inflation shock
|
|
Apr 25
|
Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines
|
|
Apr 25
|
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
|
|
Apr 25
|
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
|
|
Apr 23
|
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
|
|
Apr 22
|
25 Richest Billionaires in Healthcare Industry
|
|
Apr 22
|
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
|
|
Apr 7
|
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer
|
|
Mar 31
|
The 3 Best Bargain Stocks to Buy in Q2 2024
|